|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2007-9-7
|
|
pubmed:abstractText |
Recently, a multicenter study in differentiated thyroid cancer (DTC) patients showed that 3700 MBq 131-iodine ((131)I) after recombinant human TSH (rhTSH) had a successful thyroid ablation rate similar to that obtained after thyroid hormone withdrawal. We investigated whether 1850 MBq (131)I had a similar successful rate to 3700 MBq in patients prepared with rhTSH.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0021-972X
|
|
pubmed:author |
pubmed-author:BrianzoniErnestoE,
pubmed-author:BurroniLucaL,
pubmed-author:CapoccettiFrancescaF,
pubmed-author:CastagnaMaria GraziaMG,
pubmed-author:CipriClaudiaC,
pubmed-author:FattoriSaraS,
pubmed-author:FerrettiFrancescaF,
pubmed-author:GuarinoElisaE,
pubmed-author:PaciniFurioF,
pubmed-author:PilliTaniaT,
pubmed-author:PoggiuAngelaA,
pubmed-author:RossiGloriaG,
pubmed-author:VattimoAngeloA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3542-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17609306-Adult,
pubmed-meshheading:17609306-Aged,
pubmed-meshheading:17609306-Carcinoma,
pubmed-meshheading:17609306-Chemotherapy, Adjuvant,
pubmed-meshheading:17609306-Disease Progression,
pubmed-meshheading:17609306-Female,
pubmed-meshheading:17609306-Humans,
pubmed-meshheading:17609306-Iodine Radioisotopes,
pubmed-meshheading:17609306-Male,
pubmed-meshheading:17609306-Middle Aged,
pubmed-meshheading:17609306-Neoplasm, Residual,
pubmed-meshheading:17609306-Neoplasm Metastasis,
pubmed-meshheading:17609306-Radiometry,
pubmed-meshheading:17609306-Radiotherapy Dosage,
pubmed-meshheading:17609306-Recombinant Proteins,
pubmed-meshheading:17609306-Salvage Therapy,
pubmed-meshheading:17609306-Thyroid Neoplasms,
pubmed-meshheading:17609306-Thyrotropin
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer.
|
|
pubmed:affiliation |
Department of Internal Medicine, Endocrinology and Metabolism and Biochemistry, Section of Nuclear Medicine, University of Siena, 53100 Sienna, Italy.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
